trialx.com/curetalks_newsletter/alzheimers-or-dementia-whats-the-difference/
July 26, 2018
UPCOMING/Recent Talks

Alzheimer's or Dementia. What's the Difference?

with Dr. Murray Grossman & Dr. David Wolk
August 8th, 2018. 3 PM EST RSVP
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However, FTD and Alzheimer's are very often misdiagnosed for each other and even the terms are used interchangeably. In reality, they are two different diseases that have varying effects on behavior. It is important to differentiate between the two so that patients and families can know what to expect and receive targeted therapies. Join us as we discuss FTD and Alzheimer's Disease, their similarities, differences, risk, diagnostic tests, progression stages, treatments and clinical trials with Dr. Murray Grossman and Dr. David Wolk from the University of Pennsylvania.
Panelists
Dr. Murray Grossman
Dr. David Wolk 
Patricia W White 
 
Priya Menon 
August 16th, 2018. 1PM EST
A mother’s immune system is altered during pregnancy so that the fetus is not rejected by her body and is allowed to grow. When this balance goes awry, the immune system may become the cause of a miscarriage or multiple miscarriages. We are talking to Dr. Jeffrey Braverman, a world leader in reproductive immunology, about the role of immune system in recurrent miscarriages. Dr. Braverman will talk about various immunity related conditions or issues that may the cause of recurrent miscarriages, and also highlight the advances in the diagnosis and management of immune related pregnancy complications.
Panelists
Dr. Jeffrey Braverman
Annie Kuo
Shweta Mishra 
July 9th, 2018. 10 AM EST LISTEN
The treatment field of Multiple Myeloma continues to move forward as novel agents and treatment combinations expand. Whether you are standard risk patient or belong to high-risk group, treatment paradigms are getting better. We talked to Dr. Mateos on Myeloma research and treatment modalities discussed and presented at the recently concluded American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) annual meetings.

 


Panelists
Dr. Maria-Victoria Mateos 
Gary Petersen 
Jack Aiello 
Matt Goldman 
Yelak Biru
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks